Jeffrey N Weitzel
Overview
Explore the profile of Jeffrey N Weitzel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
11124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chavarri-Guerra Y, Rodriguez-Olivares J, Ramirez-Gonzalez A, Moreno-Miron J, Lagunas-Medina A, Penafort-Zamora J, et al.
Genet Med Open
. 2024 Dec;
2(Suppl 2):101874.
PMID: 39712971
Purpose: The purpose of this manuscript is to show the process of the establishment and adaptation of an oncogenetics program in Mexico. Methods: The oncogentics program at the Instituto Nacional...
2.
Huang H, Couch R, Karam R, Hu C, Boddicker N, Polley E, et al.
Clin Cancer Res
. 2024 Nov;
31(1):130-138.
PMID: 39513960
Purpose: To determine the relationship between germline pathogenic variants (PV) in cancer predisposition genes and the risk of ductal carcinoma in situ (DCIS). Experimental Design: Germline PV frequencies in breast...
3.
Chavarri-Guerra Y, Ferrigno-Guajardo A, Villarreal-Garza C, Martinez-Cannon B, Abugattas-Saba J, Fontaine A, et al.
JCO Glob Oncol
. 2024 Oct;
10:e2400097.
PMID: 39481075
Purpose: Women with pathogenic variants (PVs) in breast cancer (BC) and ovarian cancer (OC) associated genes are candidates for cancer risk-reducing strategies. Limited information is available regarding risk-reducing surgeries (RRS)...
4.
Akamandisa M, Boddicker N, Yadav S, Hu C, Hart S, Ambrosone C, et al.
medRxiv
. 2024 Oct;
PMID: 39417132
Importance: Pathogenic variants (PVs) in , and are associated with increased breast cancer risk. However, it is unknown whether breast cancer risk differs by PV type or location in carriers...
5.
Schrock-Kelley S, Souter V, Hall M, Sha Y, Sengupta U, ElNaggar A, et al.
Commun Med (Lond)
. 2024 Sep;
4(1):185.
PMID: 39349798
Background: Approximately 15% of colorectal cancers (CRCs) are associated with germline mutations. There is increasing adoption of DNA-based assays for molecular residual disease (MRD) and growing evidence supporting its clinical...
6.
Rodriguez-Olivares J, Kimball T, Jeter J, De-La-Mora-Molina H, Nunez I, Weitzel J, et al.
Pancreatology
. 2024 Sep;
24(7):1049-1056.
PMID: 39327123
Background: Although universal germline genetic testing is recommended for patients with exocrine pancreatic cancer (PC), access to genetic testing remains limited in low- and middle-income countries. This study aims to...
7.
Zanti M, OMahony D, Parsons M, Dorling L, Dennis J, Boddicker N, et al.
medRxiv
. 2024 Sep;
PMID: 39281752
Clinical genetic testing identifies variants causal for hereditary cancer, information that is used for risk assessment and clinical management. Unfortunately, some variants identified are of uncertain clinical significance (VUS), complicating...
8.
Kalia S, Boddicker N, Yadav S, Huang H, Na J, Hu C, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Sep;
33(11):1490-1499.
PMID: 39259185
Background: Breast cancer has been associated with monogenic, polygenic, and epidemiologic (clinical, reproductive, and lifestyle) risk factors, but studies evaluating the combined effects of these factors have been limited. Methods:...
9.
Rivero-Garcia P, Chavarri-Guerra Y, Rodriguez Olivares J, Weitzel J, Herzog J, Candanedo-Gonzalez F, et al.
Heliyon
. 2024 Jul;
10(11):e31855.
PMID: 38947473
Lynch syndrome (LS) is the most frequent cancer predisposition syndrome affecting the colon and rectum. A pathogenic variant (PV) disrupting one of the mismatch repair (MMR) genes is responsible for...
10.
Chavarri-Guerra Y, Weitzel J
JCO Clin Cancer Inform
. 2024 Jun;
8:e2400076.
PMID: 38862139
Advancements in variant curation challenges: minority representation and incomplete data reporting.